Textured Implants –Allergan 410 Implants and Sientra
You may have heard recent media reports regarding breast implants and a rare form of cancer called Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL). The Food and Drug Administration (FDA) recently updated information regarding BIA-ALCL and the American Society of Plastic Surgeons is working closely with the FDA to monitor the disease. I want our patients with breast implants to be informed about BIA-ALCL and the FDA’s recommendation related to this disease.
BIA-ALCL is not a breast cancer, but a rare and treatable T-cell lymphoma–a cancer of the cells of the immune system–that usually develops as a fluid swelling around the breast implants.
According to the FDA, data suggest that BIA-ALCL occurs more frequently following implantation of breast implants with textured surfaces rather than those with smooth surfaces, but more work needs to be done to understand the disease.
The FDA is not recommending removal of textured implants. Rather, the FDA recommends women monitor the breast implants and contact their doctors immediately if they notice pain, swelling or any changes in or around their breast implants. Further, I encourage women with implants to have an annual examination by a plastic surgeon. If any pain, swelling, lumps or asymmetry of the breast is noted, please contact our office right away at 303-860-7900. We will schedule you for a comprehensive evaluation and order the appropriate tests to determine if any treatment is indicated.
Women who develop BIA-ALCL can often be cured by having the implant and the scar tissue surrounding the implant removed. Some patients may require additional treatment such as chemotherapy or radiation therapy. Following removal, replacement with a smooth surface implant may be an option.
Additional information about BIA-ALCL is available in several places:
The American Society of Plastic Surgeons website at https://www.plasticsurgery.org/for-medical-professionals/health-policy/bia-alcl-physician-resources
If you have questions or concerns, please call me at 303-860-7900 Monday through Friday, 8:30 am to 4:30 pm.
The safety and well-being of my patients remains my highest priority. We will continue to monitor these developments closely to keep you informed of any new developments.